Thursday, September 19

Skye Bioscience's Developing Treatment for Glaucoma

Join us for a discussion about Skye Bioscience's developing treatment for glaucoma using a synthetic cannabinoid. Our guest, CEO of Skye Bioscience, Punit Dhillon, breaks down this new innovation further with our guest Alicia Nieves.

Host

Share